ArticleFrontiers in medicine2026
Estimated pulse wave velocity and dipstick proteinuria in young adults with MASLD: a cross-sectional health-check analysis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The estimated pulse wave velocity (ePWV) is a non-invasive surrogate measure of arterial stiffness that has been associated with cardiovascular risk and renal abnormalities. However, studies exploring the association between ePWV and dipstick proteinuria in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)-a condition associated with an increased risk of chronic kidney disease (CKD)-are scarce. This study aimed to investigate the association between ePWV and dipstick proteinuria in patients with MASLD. Methods: This cross-sectional study included 1,641 MASLD patients from a cohort of individuals who underwent health check-ups at a tertiary hospital in Beijing, China. ePWV was calculated using an established equation based on age and mean arterial pressure (MAP). Participants were stratified based on ePWV tertiles. Multivariable logistic regression models were used to assess the relationship between ePWV and dipstick proteinuria, adjusting for potential confounders such as age, sex, BMI, and comorbid conditions. Subgroup analyses were performed according to sex, diabetes, hyperuricemia, dyslipidemia, Results: Unadjusted and adjusted models consistently showed that higher ePWV was associated with higher odds of dipstick proteinuria. In the highest ePWV tertile, the odds of dipstick proteinuria were higher compared to the lowest tertile (OR: 2.44, 95% CI: 1.20-5.67, Discussion: Higher ePWV was associated with an increased likelihood of dipstick proteinuria among patients with MASLD. Further longitudinal studies are needed to determine whether ePWV is associated with subsequent urinary protein abnormalities and kidney outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.